. Biotinylated proteins were purified using Avidin resin after reaction. The input before avidin purification (lanes 1-3), flow through (lanes [4] [5] [6] , and elution (lanes 7-9) were separated by SDS-PAGE and visualized by SYPRO ® Ruby stain. A control reaction was carried out with HeLa cell lysates not treated with OA (lanes 1, 4, and 7). The image is a representative of two replicates. A portion of Figure S1 is shown in Figure 2A of the manuscript. OA 1uM - 1.5 a Protein hits observed in the K-BIPS study with OA mediated phosphatase inactivation. The TMT reporter intensity observed for each sample (-OA: Without okadaic acid, +OA: With okadaic acid) for the two trials (T1: trial 1, T2: trial 2) is shown. Fold change for each trial was calculated by dividing the TMT reporter intensity observed in the okadaic acid untreated sample (phosphatase active) by the TMT reporter intensity observed for the okadaic acid treated sample (phosphatase inactive). Infinity (∞) signifies that no TMT reporters were observed in the okadaic acid treated sample, making a numeric ratio calculation impossible. The known substrates of the inhibited phosphatases are green colored. The K-BIPS hits that are not previously known substrates, but known to interact with the inhibited phosphatases, are blue colored. Proteins are ordered according to the fold change value. The primary literature demonstrating that K-BIPS hits are known phosphatase substrates is provided with the gene name. When no citation is provided, interactions information was obtained from Uniprot or BioGrid databases. a Protein hits observed in the K-BIPS study with PP1-Gadd34 inactivation. The peptide intensity observed for each sample (-Gb: Without guanabenz, +Gb: With guanabenz) for the two trials (T1: trial 1, T2: trial 2) is shown. Fold change for each trial was calculated by dividing the peptide intensity observed in the guanabenz untreated sample (PP1-Gadd34 active) sample by the peptide intensity observed for the guanabenz treated sample (PP1-Gadd34 inactive). Infinity (∞) signifies that no peptides were observed in the guanabenz treated sample, making a numeric ratio calculation impossible. EIF2S1 (eIF2α), the known substrate of PP1-Gadd34 is green colored. Except when cited, information on functional association was obtained from Uniprot. Proteins are ordered according to the fold change. Figure 4A of the manuscript. Figure 4A of the manuscript. Figure 4A of the manuscript. Figure 4A of the manuscript. 
Figure S14: COPS5 and G3BP1 protein levels as a function of Guanabenz treatment. HeLa cells were treated with combination of Tunicamycin (Tm), Guanabenz (Gb), Sephin1 (Seph), and/or ISRIB at 37°C for 6 hours. The treated cells were lysed before the proteins in the lysates were separated by 10% SDS-PAGE. Levels of G3BP1 and COPS5 were probed by Western blot using primary antibodies (anti-COPS5 and anti-G3BP1) and HRP conjugated secondary antibody. Sypro®Ruby staining (bottom gel) of the lysates showed equal protein loading. Three independent trials are shown. . Biotinylated proteins were enriched using streptavidin resin and the input, flow through, wash, and the elution were run on a SDS-PAGE gel. COPS5 levels were monitored by Western blot. Three trials are shown in the three gel images. The top trial is shown in Figure 4B .
Figure S17: Validation of COPS5 using Phos-tag™ SDS-PAGE. HeLa cells were treated with Tm and Gb, or Tm alone. After lysis, proteins were separated using Phos-tag™ SDS-PAGE. COPS5 was visualized with COPS5 primary antibody and HRP-conjugated secondary antibody. Total proteins were visualized as a load control by Sypro®Ruby total protein stain. Three independent trials are shown. Trial 1 is shown in Figure 4C of the manuscript. 
